Skip to main content

Animations

MJFF Publications

6061 - 6070 of 8824 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2020
  • 2024
  • 2024
  • 2021
  • 2024
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Real-World Experiences of Parkinson's Disease OFF Time and Role of Demographics
    Journal Name: Journal of Patient-Centered Research and Reviews
    Publisher: Aurora Health Care, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.17294/2330-0698.2057
    Citation Count: 3
  • Summary Details
    OPEN
    Title: MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00083-8
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.4c00602
    Citation Count: 2
  • Summary Details
    OPEN
    Title: KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa304
    Citation Count: 106
  • Summary Details
    OPEN
    Title: Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00685-3
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00706-1
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-021-03185-z
    Citation Count: 113
  • Summary Details
    OPEN
    Title: Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-02886-y
    Citation Count: 106
  • Summary Details
    OPEN
    Title: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-022-01140-3
    Citation Count: 236
  • Summary Details
    OPEN
    Title: Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41594-022-00863-y
    Citation Count: 53
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.